A Recombinant System and Reporter Viruses for Papiine Alphaherpesvirus 2

Abdul Rahman Siregar1,2,3, Sabine Gärtner1, Jasper Götting4

  • 1German Primate Center, Infection Biology Unit, Leibniz Institute for Primate Research, 37077 Gottingen, Germany.

Viruses
|January 22, 2022
PubMed

Insights

Researchers developed a new system to study Papiine alphaherpesvirus 2 (PaHV2) and its potential to cause disease. This tool will help understand why PaHV2 may be less dangerous than similar viruses, aiding future research on neuropathogenicity.

Area of Science:

  • Virology
  • Neuroscience
  • Molecular Biology

Background:

  • Primate alphaherpesviruses establish latent infections in neurons.
  • Zoonotic transmission of Macacine alphaherpesvirus 1 (McHV1) causes severe human disease.
  • Papiine alphaherpesvirus 2 (PaHV2) shares properties with McHV1 but human infections are unreported, suggesting differing pathogenicity.

Purpose of the Study:

  • To develop a recombinant system for studying Papiine alphaherpesvirus 2 (PaHV2).
  • To enable molecular analyses of PaHV2 neuropathogenicity.
  • To investigate potential differences in pathogenicity between PaHV2 and McHV1.

Main Methods:

  • Development of a recombinant system for PaHV2 rescue.
  • Utilizing recombineering to insert reporter genes (Gaussia luciferase or enhanced green fluorescent protein) into PaHV2.
  • Assessing replication efficiency of engineered viruses compared to wild-type PaHV2.

Main Results:

  • Successful rescue of recombinant PaHV2.
  • Generation of reporter viruses (PaHV2-Gluc, PaHV2-eGFP) that replicate efficiently.
  • Demonstration of the utility of these viruses for analyzing cell susceptibility and antiviral compound efficacy.

Conclusions:

  • A functional recombinant system for PaHV2 has been established.
  • This system facilitates molecular studies of PaHV2 neuropathogenicity.
  • Future research can now investigate the mechanisms underlying differential pathogenicity of primate alphaherpesviruses.

Related Concept Videos